Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Invite your friends, family, colleagues or clients to an exceptional black-tie event in the heart of London. Every ticket, every bid, every moment helps us move closer to a cure.
Our ambitious new roadmap is aimed at driving significant advancements in type 1 diabetes research, treatment, and care.
Join the type 1 diabetes community and come together, raising awareness and vital funds for T1D.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
JDRF has now rebranded to Breakthrough T1D. Our name has changed, our mission has not.
Home > News & events > News > Connect Immune Research partnership welcomes the Royal Free Charity
Connect Immune Research is a pioneering initiative, which unites organisations that conduct research on specific autoimmune conditions and enables them to collaborate on research projects. Autoimmune conditions involve the body’s immune system attacking its own cells instead of harmful invaders such as viruses and bacteria.
Part of the Royal Free Charity’s core work is supporting the researchers working in their hospitals and partner institutes. Their focus on early-stage research helps provide a solid foundation of knowledge that boosts the potential of other research into treatments and cures.
There is evidence that autoimmune conditions may share similar underlying biology, so Connect Immune Research is about joining forces to fund research that tackles many conditions at once.
Jon Spiers, Chief Executive of the Royal Free Charity, said: “This is a very important alliance for the health research community, and we’re delighted to add our perspective as an NHS charity with a huge research focus.
“Connect Immune Research (CIR) mirrors our commitment to collaboration: the Royal Free Charity works at the intersection of philanthropy, translational research and clinical service delivery within the NHS. Having co-funded the new Pears Building in Hampstead, home of the UCL Institute of Immunity and Transplantation, now the largest immunology institute in Europe, we look forward to working with CIR members to contribute to immunology research excellence in the UK so that together we can go further, faster, for all patients.”
The diverse range of research fields that the Royal Free Charity supports makes them a huge asset to Connect Immune Research. The UCL Institute of Immunity and Transplantation will be especially pivotal as a key research goal of theirs is to better understand the biology of immune regulation. This foundation of knowledge will help all partners to develop therapies addressing the abnormal immune system activity that occurs in each autoimmune condition.
Dr Doug Brown, CEO of the British Society of Immunology, said: “We’re delighted to welcome the Royal Free Charity to Connect Immune Research, and I know that they’ll make a valuable contribution to the work of this important initiative. The work that the Royal Free Charity does to support hospitals, NHS staff, and patients is incredibly valuable. Their involvement will help us to realise our vision of advancing treatments for people living with autoimmune conditions.”
We've partnered with Barbie to create the world’s first Barbie doll with type 1 diabetes (T1D).
A recent study has shown that a treatment currently used for type 2 diabetes could be used to help prevent kidney damage in young adults with type 1
We’re aware of growing concern around insulin supply in the UK, and we want to reassure our community that this is not a general insulin shortage. There is no need to change the type of insulin you use.
New data from Sana Biotechnology, in collaboration with Uppsala University Hospital in Sweden, shows that six months post-transplant, one person with type 1 diabetes (T1D) is successfully producing insulin and does not require immunosuppression.
Don’t miss out on the latest research, inspiring stories, tech news, upcoming events, and handy information on living well with type 1. Join us now and receive it all straight to your inbox.
It’s thanks to your dedication that we have funded great progress in type 1 cure, treatment and prevention research. Help us to continue our vital research.
